Nel ASA Faces Credibility Gap Between Next-Gen Electrolyser and Deteriorating Fundamentals
Published on 07/19/2026 at 08:43 | Redaktion boerse-global.de
The Norwegian hydrogen specialist Nel ASA finds itself trapped between a promising technological overhaul and mounting evidence that its business model has yet to achieve commercial viability. Shares closed at €0.1922 on Friday, shedding 1.94% in a single session and leaving the stock 47.41% below the 52-week high of €0.3655 reached on 25 May 2026. The market has effectively erased nearly half the company's value in under two months.
At the heart of the sell-off lies a fundamental disconnect. Nel trades at a price-to-sales ratio of roughly 4.4 — a hefty premium to the broader European electrical equipment sector's multiple of around 1.4 and far above the 1.2 commanded by direct competitors. That premium looks increasingly difficult to defend given the company's persistent losses. Over the trailing twelve months, Nel booked a loss per share of 0.70 Norwegian kroner on revenue of 906.4 million kroner, and analysts see no near-term path to profitability.
Q2 results underscore the gap
The second quarter of 2026 did little to close the narrative gap. Revenue came in at 181.7 million Norwegian kroner, down from 215 million in the same period a year earlier. The net loss for the quarter reached 188.6 million kroner, or 0.10 kroner per share. On an EBITDA basis, the shortfall hit negative 155 million kroner — a figure that includes a one-off settlement payment of 70 million kroner related to the Iwatani case. Strip that out and the underlying operating loss still remains substantial.
Over the past five quarters, Nel's net losses have swung between 84.7 million and 870.4 million kroner, with cumulative losses over the last twelve months reaching 1.3 billion kroner. Revenue during that span ranged from 148.1 million to 330.5 million kroner, illustrating the operational volatility that makes forecasting — and by extension valuation — so challenging.
Should investors sell immediately? Or is it worth buying Nel ASA?
Technology bet carries execution risk
Management has pinned its turnaround hopes on a new pressurised alkaline electrolyser platform, which promises to cut footprint by 80% and reduce investment costs by 40% to 60%. The product launched in May, and first orders are expected in the coming months. The European Union is backing the PA-Series line with €135 million in funding, and Nel plans to ramp capacity to 500 megawatts by the end of 2026 and one gigawatt the following year.
Yet the market appears to be pricing in execution risk rather than the EU-subsidised capacity expansion. The stock now sits 24.54% below its 50-day moving average, and the 200-day average of €0.2153 — a level breached early this year — has flipped from support to resistance. Nel currently trades 10.73% beneath that line. A relative strength index of 30.0 signals oversold territory, but technical readings alone cannot repair a profit-and-loss statement.
Cash cushion buys time
Nel still has some breathing room. The order intake for the second quarter rose to 230 million kroner after several lacklustre quarters, leaving the order backlog at 1.2 billion kroner. Cash on hand stands at 1.3 billion kroner, enough to fund operations for the foreseeable future without an immediate capital raise. With a market capitalisation of roughly €362 million, the company's net cash position accounts for a significant portion of the equity value.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
For the year to date, Nel shares cling to a 1.80% gain, meaning the recent selling has merely consumed the early-year advance. Over twelve months the stock has lost 13.97%, a reminder that the entire hydrogen sector has repeatedly revised down its assumptions about financing and demand.
The real test now is not a single headline or a technical bounce. It is whether the order momentum from the new alkaline platform materialises in the financial statements before the ongoing downtrend retests the 52-week floor at €0.1731. As long as losses persist, the valuation premium will remain under scrutiny — and the technology bet will need to deliver more than promise.
Ad
Nel ASA Stock: New Analysis - 19 July
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
